See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · SLAS2012 1st Annual Conference & Exhibition · San Diego, California · February 4-8, 2012 · Booth 445

Research Area · Cardiology

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
12730 15(S)-15-methyl Prostaglandin D2 85280-90-6 >95% 55.970460405156 15-s-15-methyl-prostaglandin-d2 15(S)-15-methyl PG2 15(S)-15-methyl-PGD2 prostaglandins vasoconstriction analogs 15S-15-methyl-PGD2 55.970460405156
12750 16,16-dimethyl Prostaglandin D2 64072-59-9 >98% 161.844806629835 16-16-dimethyl-prostaglandin-d2 16,16-dimethyl PGD2 16,16-dimethyl-PGD2 prostaglandins 161.844806629835
13050 1a,1b-dihomo Prostaglandin E1 - >98% 18.468158379374 1a-1b-dihomo-prostaglandin-e1 1a,1b-dihomo PGE1 1a,1b-dihomo-PGE1 prostaglandins 18.468158379374
9000462 2,3-dinor-6-keto Prostaglandin F-d9 (sodium salt) - ≥99% deuterated product 2010-05-07 21.541060773481 2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt 2,3-dinor-6-keto PGF1α-d9 (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated 21.541060773481
515121 2,3-dinor-6-keto Prostaglandin F EIA Kit - 2006-05-23 161.747834254144 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 161.747834254144
15120 2,3-dinor-6-keto Prostaglandin F (sodium salt) - ≥95% 16.741961325967 2-3-dinor-6-keto-prostaglandin-f1-sodium-salt 2,3-dinor-6-keto PGF1α (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins 16.741961325967
13120 2,3-dinor Prostaglandin E1 7046-40-4 >98% 29.757375690607 2-3-dinor-prostaglandin-e1 2,3-dinor PGE1 prostaglandins 2,3-dinor-PGE1 erectile dysfunction 29.757375690607
13260 6-keto Prostaglandin E1 67786-53-2 >99% 71.984751381215 6-keto-prostaglandin-e1 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins 71.984751381215
10007210 6-keto Prostaglandin E1 Lipid Maps MS Standard 67786-53-2 >99% 2008-11-03 47.771786372007 6-keto-prostaglandin-e1-lipid-maps-ms-standard 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 47.771786372007
15210 6-keto Prostaglandin F 58962-34-8 >99% 57.938254143646 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 57.938254143646
515211 6-keto Prostaglandin F EIA Kit - 512.613747697974 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 512.613747697974
10007219 6-keto Prostaglandin F Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 37.641591160221 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 37.641591160221
10010002 6-keto Testosterone Enanthate Exclusive - >98% 2007-07-12 0.206261510129 6-keto-testosterone-enanthate esters androgens testosterone heptanoate analogs endocrinology 0.206261510129
10010003 6α-Testosterone Enanthate Exclusive - >98% 2007-07-13 0.618784530387 6-testosterone-enanthate esters androgens testosterone heptanoate analogs 6alpha-testosterone enanthate 6.alpha.-Testosterone enanthate endocrinology 0.618784530387
10010004 6β-Testosterone Enanthate Exclusive - >98% 2007-07-13 0.206261510129 6-testosterone-enanthate 6beta-Testosterone enanthate 6.beta.-Testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology 0.206261510129
13360 8-iso Prostaglandin E1 21003-46-3 >98% 65.287513812154 8-iso-prostaglandin-e1 Ovinonic acid; 8-iso PGE1; 8-epi PGE1 8-iso-PGE1 8-epi-PGE1 8-isoprostanes vasoconstriction prostaglandins 65.287513812154
700260 Alanine Transaminase Activity Assay Kit - 2010-01-06 221.315511701495 alanine-transaminase-activity-assay-kit ALT Activity Assay Kit; ALAT Activity Assay Kit; Alanine Aminotransferase Activity Assay Kit; sGPT Activity Assay Kit; Serum Pyruvic Transaminase Activity Assay Kit alanines aminotransferases homodimeric cytoplasmic pyridoxal phosphate-enzymes cells cellular nitrogen metabolism amino acids transamination a-ketoglutarates alpha-ketoglutarates α-ketoglutarates pyruvates glutamates tissues livers kidneys heart brains glucose neuronal glutamates alanine-aminotransferases reactions diseases injury diabetes cirrhosis fatty hepatitis carcinomas mononucleosis muscular dystrophy cardiovascular serums plasmas samples lysates NADH oxidations lactate dehydrogenases LDH NAD+ assays kits measures measurements 221.315511701495
700420 Ascorbate Assay Kit - 2010-09-01 197.117924018014 ascorbate-assay-kit L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD 197.117924018014
10532 BayCysLT2 Exclusive 712313-33-2 ≥95% 2010-09-22 4.305653775322 baycyslt2 CAY10633 HAMI3379 cysLT2 receptors cardiovascular disease antagonists leukotrienes LTC4 LTD4 cysteinyl HAMI 3379 HAMI-3379 cyslts CAY10633 CAY-10633 CAY 10633 4.305653775322
10155 BM 567 284464-77-3 >98% 2005-03-31 44.169010128913 bm-567 platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege 44.169010128913
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 8.267679558011 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 8.267679558011
13281 CAY10598 Exclusive 346673-06-1 ≥98% 2010-05-07 68.911458563535 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 68.911458563535
10012447 CG 4305 - ≥95% 2010-05-12 48.643291239147 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 48.643291239147
600440 Cholesterol Uptake Cell-Based Assay Kit - 2011-06-28 40.420202843887 cholesterol-uptake-cell-based-assay-kit assays kits measures measurements cells hormones intermediates bile acids biosynthesis body cholesterols homeostasis de novo dietary absorption biliary clearance excretion plasma hypercholesterolemia cardiovascular diseases serum hepatic Ezetimibe inhibitors inhibits inhibition intestinal uptake enterocytes proteins Niemann-Pick C1 Like 1 NPC1L1 genes influx efflux intraluminal molecules membranes modulators NBD cultured U18666A inhibitor inhibits inhibition positive controls U 18666A U-18666A 40.420202843887
10956 Clofibrate 637-07-0 ≥98% 2004-09-14 20.835156537752 clofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate 20.835156537752
13657 (±)-Clopidogrel (hydrochloride) 90055-48-4 ≥98% 2011-04-11 0E-12 -clopidogrel-hydrochloride platelets aggregation antagonists P2Y12 receptors ADPs prodrugs anti-thrombic antithrombic 0E-12
13352 EHNA (hydrochloride) New - ≥98% 2011-10-07 653.841694290976 ehna-hydrochloride 51350-19-7 79763-32-9 59262-86-1 ADA reversible adenosine deaminase inhibitors inhibits inhibition cGMP PDE2 potent PDE1 PDE3 PDE4 phosphodiesterase ardioprotective ischemia stem cells 653.841694290976
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated product 2005-08-30 225.205591160221 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 225.205591160221
10007432 FABP3 (human recombinant) - >95% 2005-07-27 28.334175874769 fabp3-human-recombinant Heart-FABP; Fatty Acid Binding Protein-3; H-FABP protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology 28.334175874769
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 11.731571516267 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 11.731571516267
10009549 FABP4 (human recombinant) - >90% 2007-06-15 32.261976200594 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 32.261976200594
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.691125690607 fabp4-human-recombinant-western-ready-control A-FABP; FABP4; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4 fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.691125690607
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 11.970839779005 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 11.970839779005
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 6.356127992633 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 6.356127992633
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 22.263124616329 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 22.263124616329
700300 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit - 2011-07-28 88.789759425657 glucose-6-phosphate-dehydrogenase-activity-assay-kit G6PDH Activity Assay Kit kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent 88.789759425657
13311 Gö 6983 133053-19-7 ≥98% 2009-10-07 42.004782074892 g-6983 proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983 42.004782074892
10580 HAMI3379 Exclusive 712313-35-4 ≥90% 2011-03-14 87.915256511444 hami3379 cysLT2 receptors cardiovascular diseases antagonists leukotrienes LTC4 LTD4 cysteinyl LTs CysLTs perfusion pressure decrease contractility cyclohexanecarboxylic acids 87.915256511444
13705 HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28) - 2009-12-01 0E-12 hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 0E-12
13707 HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37) - 2009-12-01 0E-12 hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP 0E-12
13708 HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28) - 2009-12-01 0E-12 hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 0E-12
13709 HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10) - 2009-12-02 0E-12 hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates 0E-12
10009377 HDAC2 (human recombinant) - >70% by SDS-PAGE 2006-12-06 33.099761843672 hdac2-human-recombinant Histone Deacetylase 2 HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 33.099761843672
10009379 HDAC5 (human recombinant) - >90% by SDS-PAGE 2006-12-06 34.210483294935 hdac5-human-recombinant Histone Deacetylase 5 HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 34.210483294935
10009466 HDAC9 (human recombinant) - >95% 2007-06-14 21.009529094375 hdac9-human-recombinant GenBank Accession No. NM 178423; Histone Deacetylase 9 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 21.009529094375
700540 Hemoglobin Colorimetric Assay Kit - 2011-05-23 125.995650910578 hemoglobin-colorimetric-assay-kit kits assays measures measurements Hb Hgb globular proteins oxygen O2 lungs tissues cells carbon dioxide CO2 erythrocytes human molecules subunits chains heme groups charged iron Fe Fe2+ tetrapyrrole rings porphyrin covalent bonds monoxide nitric oxides NO hypoxia thiol S-nitrosothiol vasodilatory effects transport hypoxic red blood RBCs vessels sickle-cell anemia thalassemia bone marrow diseases kidney diabetes 125.995650910578
13624 Icariin 489-32-7 ≥97% 2010-02-11 1.971491712706 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans 2 Phenyl Benzopyrans 2-Phenyl-Chromenes 2 Phenyl Chromenes Bioflavonoids Flavonoids 1.971491712706
13711 KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10) - 2009-12-02 0E-12 kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate 0E-12
13714 Kir2.1 Potassium Channel Monoclonal Antibody (Clone S21-32) - 2009-12-02 0E-12 kir2-1-potassium-channel-monoclonal-antibody-clone-s21-32 channels antibodies western blots blotting immunoblotting WB immunohistochemistry IHC KCNJ2 genes Andersen-Tawil syndromes Andersen Tawil AT defects 0E-12
13715 Kir2.2 Potassium Channel Monoclonal Antibody (Clone S24-1) - 2009-12-02 0E-12 kir2-2-potassium-channel-monoclonal-antibody-clone-s24-1 channels ions antibodies western blots blotting immunoblotting WB immunohistochemistry IHC syndromes Smith-Magenis Smith Magenis chromosomes 17 seventeen tissues genes 0E-12
13716 Kir2.3 Potassium Channel Monoclonal Antibody (Clone S25-35) - 2009-12-04 0E-12 kir2-3-potassium-channel-monoclonal-antibody-clone-s25-35 antibodies channels ions western blots blotting immunoblotting WB IHC immunohistochemistry genes proteins potassiums 0E-12
13810 Limaprost 74397-12-9 >98% 41.706850828729 limaprost 17α,20-dimethyl-Δ2-Prostaglandin E1; 17α,20-dimethyl-Δ2-PGE1 PGE1 analogs inhibitors platelets aggregation prostaglandins 41.706850828729
390150 Linoleic Acid-d4 Exclusive 79050-23-0 ≥99% deuterated product 16.963204419889 linoleic-acid-d4 standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids 16.963204419889
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 9.354198895028 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 9.354198895028
13357 Milrinone 78415-72-2 ≥98% 2011-03-07 266.891267034991 milrinone Primacor®; WIN 47203 inhibitors phosphodiesterases PDE3A PDE3B cAMP vascular diseases cardiovascular effects Sanofi Synthelabo Brand of Milrinone Lactate Sanofi Winthrop Brand of Milrinone Lactate Sanofi Synthelabo Brand of Milrinone Sanofi Brand of Milrinone Lactate Lactate Milrinone Milrinone Lactate Win-47203 Win 47203 Milrinone Corotrope Win47203 Primacor Corotrop inhibits inhibition 266.891267034991
585001 Myeloperoxidase (human) EIA Kit - 2009-05-05 33.812348066298 myeloperoxidase-human-eia-kit MPO (human) EIA Kit myeloperoxidases controls standards EIAs ELISAs enzymes immunometrics assays leukocytes oxidants atherosclerotic atherosclerosis plaques prothrombogenicity cytotoxic cytotoxins nitric oxides vasocontrictions vasocontrictors plasma blood ACS acute coronary syndromes cardiac myocardial infarction revascularization death assays 33.812348066298
700170 Myeloperoxidase Inhibitor Screening Assay Kit - 2009-04-14 93.619790055248 myeloperoxidase-inhibitor-screening-assay-kit MPO Inhibitor Screening Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays 93.619790055248
700160 Myeloperoxidase Peroxidation Assay Kit - 2009-04-14 107.839060773480 myeloperoxidase-peroxidation-assay-kit MPO Peroxidation Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 107.839060773480
9000537 N-Desethylamiodarone (hydrochloride) 96027-74-6 ≥95% 2009-10-07 0E-12 n-desethylamiodarone-hydrochloride MDEA substrates CYP3A4 metabolites amiodarone cytochromes CYP-3A4 CYP 3A4 0E-12
11106 Nifedipine New 21829-25-4 ≥98% 2011-11-22 20.368618618619 nifedipine Nifediac™; BAY 1040; Procardia™; Nifedical™; Cordipin; Adalat™ dihydropyridine calcium channel blockers Ca2+ hypertension angina endothelia cardiology preterm labor Raynaud’s phenomenon pulmonary edema coronary vasodilator antioxidant gastric acids 11104-22-6 101539-70-2 101554-38-5 adalat nifediac cordipin procardia nifedical adalate adapine adapress alat alfadat alonix angipec anifed BAY-1040 BAY1040 BAY-a BAYa BAY-a 1040 bonacid calcigard calcibloc calciguard calcilat camont cardifen cardionorm chronadalate coral cordafen cordaflex cordilan corinfar corotrend corynphar depin dignokonstant dilafed dilcor duranifin ecodipin fedcor fenamon fedipin fenihidine glopir hadipine hexadilat introcar kordafen macorel megalat myogard nifedilat nifedirex nifelantern nifelat nifensar niphedipine nyefax orix oxcord pidilat procardia sepamit TN 873R TN-873R TN873R tensopin tibricol UV-ENP 349PINa vasdalat vasofed xinran zenusin 20.368618618619
10010653 Nisoldipine-d3 - ≥99% deuterated product 2009-04-15 0E-12 nisoldipine-d3 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
10350 PRMT1 (human recombinant) - ≥80% 2011-01-25 82.801232734806 prmt1-human-recombinant Protein Arginine Methyltransferase 1 PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged 82.801232734806
10752 PRMT6 (human recombinant) New - ≥80% 2012-01-24 98.064044275629 prmt6-human-recombinant Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6 PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a 98.064044275629
512031 Prostaglandin D2 EIA Kit - 2010-07-19 283.645704419890 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 283.645704419890
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 129.804781130471 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 129.804781130471
12990 Prostaglandin D3 Exclusive 71902-47-1 >98% 74.119208103131 prostaglandin-d3 PGD3 PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins 74.119208103131
13010 Prostaglandin E1 745-65-3 >98% 54.164508901165 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 54.164508901165
13010.1 Prostaglandin E1 Analytical Reference Standard 745-65-3 >99% 29.759907918968 prostaglandin-e1-analytical-reference-standard Alprostadil; PGE1 PGE1 vasodilation USP erectile dysfunction prostaglandins 29.759907918968
13082 Resorcinolnaphthalein 41307-63-5 ≥98% 2009-02-24 65.642596685083 resorcinolnaphthalein NSC 354317 angiotensin converting enzyme 2 ACE2 hypertension blood pressure activators fibrosis 65.642596685083
10012555 Sodium Hydrogen Sulfide (hydrate) 207683-19-0 ≥65% 2009-09-03 27.867152308846 sodium-hydrogen-sulfide-hydrate Sodium Hydrosulfide; NSC 158264; NaHS hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 27.867152308846
10162 Treprostinil 81846-19-7 >98% 2005-08-30 222.027567583194 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 222.027567583194
18113 YM-53601 Exclusive 182959-33-7 ≥98% 2009-08-11 5.061276243093 ym-53601 squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited 5.061276243093
90210 α-Linolenic Acid 463-40-1 >98% 12.737751381215 -linolenic-acid ALA fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic 12.737751381215
9000433 α-Linolenic Acid-d14 - ≥99% deuterated product 2010-09-13 7.118133824432 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 7.118133824432
10010001 Δ-6 Testosterone Enanthate Exclusive - >98% 2007-07-12 0.206261510129 -6-testosterone-enanthate DELTA-6-testosterone enanthate .DELTA.-6-testosterone enanthate .DELTA.6-testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology 0.206261510129
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?